Creative Medical Technology (CELZ) Competitors $3.42 +0.02 (+0.44%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ vs. RNTX, MAAQ, RVPH, ITRM, KZR, CLSD, ASBP, CASI, PMN, and TENXShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Rein Therapeutics (RNTX), Mana Capital Acquisition (MAAQ), Reviva Pharmaceuticals (RVPH), Iterum Therapeutics (ITRM), Kezar Life Sciences (KZR), Clearside Biomedical (CLSD), Aspire Biopharma (ASBP), CASI Pharmaceuticals (CASI), Promis Neurosciences (PMN), and Tenax Therapeutics (TENX). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Its Competitors Rein Therapeutics Mana Capital Acquisition Reviva Pharmaceuticals Iterum Therapeutics Kezar Life Sciences Clearside Biomedical Aspire Biopharma CASI Pharmaceuticals Promis Neurosciences Tenax Therapeutics Creative Medical Technology (NASDAQ:CELZ) and Rein Therapeutics (NASDAQ:RNTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment. Is CELZ or RNTX more profitable? Creative Medical Technology's return on equity of -82.99% beat Rein Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Creative Medical TechnologyN/A -82.99% -79.49% Rein Therapeutics N/A -141.11%-33.83% Do analysts rate CELZ or RNTX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Creative Medical Technology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Rein Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals & insiders hold more shares of CELZ or RNTX? 1.4% of Creative Medical Technology shares are owned by institutional investors. Comparatively, 90.9% of Rein Therapeutics shares are owned by institutional investors. 1.8% of Creative Medical Technology shares are owned by insiders. Comparatively, 5.1% of Rein Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor CELZ or RNTX? In the previous week, Rein Therapeutics had 1 more articles in the media than Creative Medical Technology. MarketBeat recorded 1 mentions for Rein Therapeutics and 0 mentions for Creative Medical Technology. Rein Therapeutics' average media sentiment score of 0.59 beat Creative Medical Technology's score of 0.00 indicating that Rein Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Creative Medical Technology Neutral Rein Therapeutics Positive Which has preferable valuation and earnings, CELZ or RNTX? Creative Medical Technology has higher revenue and earnings than Rein Therapeutics. Creative Medical Technology is trading at a lower price-to-earnings ratio than Rein Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreative Medical Technology$10K883.65-$5.49M-$3.18-1.08Rein TherapeuticsN/AN/A-$62.88M-$2.69-0.44 Which has more volatility and risk, CELZ or RNTX? Creative Medical Technology has a beta of 2.06, suggesting that its share price is 106% more volatile than the S&P 500. Comparatively, Rein Therapeutics has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. SummaryRein Therapeutics beats Creative Medical Technology on 7 of the 11 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.84M$3.15B$5.76B$10.03BDividend YieldN/A2.28%5.28%4.52%P/E Ratio-1.0821.4575.4326.15Price / Sales883.65427.65515.98171.98Price / CashN/A45.5837.2059.76Price / Book0.949.5911.536.20Net Income-$5.49M-$53.33M$3.28B$270.56M7 Day Performance2.54%0.61%0.42%2.70%1 Month Performance2.85%11.09%10.81%8.77%1 Year Performance1.63%12.67%61.62%27.50% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology0.2129 of 5 stars$3.43+0.4%N/A-5.3%$8.84M$10K-1.085Positive NewsRNTXRein TherapeuticsN/A$1.35-2.9%N/AN/A$32.39MN/A-0.509Gap DownHigh Trading VolumeMAAQMana Capital AcquisitionN/A$3.81+0.5%N/A+1,151.7%$30.96MN/A0.001RVPHReviva Pharmaceuticals3.0382 of 5 stars$0.45+0.7%$5.20+1,047.9%-66.9%$30.60MN/A-0.705ITRMIterum Therapeutics2.6309 of 5 stars$0.64-5.4%$9.00+1,306.3%-35.1%$30.22MN/A-0.7510Positive NewsShort Interest ↓KZRKezar Life Sciences2.3589 of 5 stars$3.83-3.0%$9.00+135.0%-29.1%$28.93M$7M-0.4060CLSDClearside Biomedical1.9945 of 5 stars$0.34-7.7%$4.20+1,138.6%-68.0%$28.85M$1.66M-0.9230News CoverageGap UpHigh Trading VolumeASBPAspire BiopharmaN/A$0.58+0.8%N/AN/A$28.49MN/A0.00N/ACASICASI Pharmaceuticals3.7386 of 5 stars$2.30-0.4%$4.00+73.9%-65.0%$28.41M$28.54M-0.80180Gap DownPMNPromis Neurosciences2.7882 of 5 stars$0.54-0.6%$4.33+707.6%-66.3%$27.97MN/A-2.565Gap UpTENXTenax Therapeutics1.6351 of 5 stars$6.00+0.1%$17.00+183.6%+62.6%$27.33MN/A-6.529News CoverageAnalyst Forecast Related Companies and Tools Related Companies Rein Therapeutics Alternatives Mana Capital Acquisition Alternatives Reviva Pharmaceuticals Alternatives Iterum Therapeutics Alternatives Kezar Life Sciences Alternatives Clearside Biomedical Alternatives Aspire Biopharma Alternatives CASI Pharmaceuticals Alternatives Promis Neurosciences Alternatives Tenax Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELZ) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersThis stock just surpassed PalantirThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemTucked away outside San Antonio sits a facility most Americans don’t know exists. It’s not mining gold or o...True Market Insiders | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | SponsoredLitecoin’s Creator Backs the World’s First TreasuryBitcoin's corporate adoption story has been written. Litecoin's is just beginning.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
